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1. Introduction
Mycobacterium tuberculosis (Mtb) is responsible for causing tuberculosis (TB) [1], a chronic re-
emerging infectious disease with a major impact on public health worldwide [2]. Primary TB
occurs by inhalation of microdroplets containing Mtb bacilli [3]. If the innate immune response
is not efficient to control and eliminate the mycobacteria, then adaptive T cell responses might
contain the bacteria resolving the infection [3-5].
Being TB a long-lasting affliction, most research on the immune responses to TB has addressed
the chronic stages. In contrast, the earliest contacts of bacilli with cells responsible of the first
defenses have been rather neglected, until recent years. Neutrophils (PMNs) are short-lived
leukocytes, functioning as the primary defense against microorganisms [6, 7], with special
ability to kill pathogens by phagocytosis, degranulation and the formation of extracellular
traps [8-11]. The activation of neutrophils is associated with changes in the spatial and temporal
expression of certain molecules [12, 13] such as CD16b, CD11b and CD66b, molecules respon‐
sible for adhesion, degranulation and migration, and are therefore well established as neutro‐
phil activation markers [13-19]. On the other hand, it is documented that intracellular
pathogens causing chronic infections can co-opt the pathway of a pair of molecules, PD-1 and
its ligand PD-L1, involved in decreasing crucial T cell responses, provoking a phenomenon
called "T cell exhaustion" [20]. In physiological conditions, this pathway is important for
peripheral tolerance and the control of adaptive immune responses [21], but it has been barely
explored in TB.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and eproduction in any medium, provided the original work is properly cited.
In this work we wanted to assess the phenotype of neutrophils during the very early interac‐
tions with three different strains from the Mycobacterium tuberculosis-complex.
2. Materials and methods
2.1. Ethics
This research was performed on healthy competent volunteers in accordance with the
Declaration of Helsinki of the world Medical Association, and the Mexican General Health
Law regarding research. The ethics committee of the National School of Biological Sciences
ENCB-IPN approved this study (permission number: “Protocolo #CEI-ENCB 011/2013”) and
informed written consent was obtained from donors.
2.2. Bacterial strains and cultures
Mycobacterium tuberculosis H37Rv, Mycobacterium canetti and Mycobacterium bovis Bacillus
Calmette-Guérin (BCG) strains were grown in Middlebrook 7H9 broth (Difco, Detroit, MI,
USA. Cat. 271310), enriched with 10% OADC (Oleic, Albumin, Dextrose, Catalase) (Becton,
Dickinson, USA. Cat. 211886) at 37°C until exponential growth phase. Bacteria were diluted
in D-MEM (Dulbecco’s modified Eagle’s medium) (Invitrogen, Grand Island, NY, USA. Cat.
12430) supplemented with 10% FBS (fetal bovine sera) (Invitrogen, Grand Island, NY, USA.
Cat. 16000). Mycobacteria were quantified prior to use.
2.3. Isolation of human neutrophils
Human blood neutrophils were isolated from healthy donors using two gradients: Histopaque
1119 (Sigma-Aldrich, St. Louis, MO, USA. Cat. 11191) for 20 min at 800g and Percoll (GE
Healthcare Bio-sciences AB, Uppsala, Sweden. Cat. 17-0891-01) at the densities indicated next:
1105 g/mL (85%), 1100 g/mL (80%), 1093 g/mL (75%), 1087 g/mL (70%) y 1081 g/mL (65%), for
20 min at 800g.
2.4. Stimulation and staining of neutrophils
106 healthy neutrophils/mL of RPMI-1640 medium supplemented with 5% fetal bovine serum
(FBS) were used either unstimulated or stimulated with 10 nM Phorbol 12-Myristate 13-Acetate
(PMA) (Sigma-Aldrich, St. Louis, MO, USA. Cat. P-81-39), 5 μg/mL LPS (Sigma-Aldrich, St.
Louis, MO, USA. Cat. L-3755), Mycobacterium bovis BCG, Mycobacterium canetti or Mycobacte‐
rium tuberculosis H37Rv at 37°C in 5% CO2 atmosphere for 15, 30 and 60 min. Subsequently,
cells were treated 5 min with universal blocking reagent (Biogenex¸ cat HK085-5K) and stained
with different combinations of purified fluorochrome-conjugated antibodies: anti-human
CD16b-APC (R&D Systems, Minneapolis, MN, USA. Cat. FAB2546A), CD66b-FITC (AbD
Serotec, Kidlington, UK. Cat. MCA216F) and CD11b-PE (BD Pharmingen, San Jose, CA, USA.
Cat. 340712). To evaluate the pro-inhibitory phenotype we used anti-human PD-1-FITC
(BioLegend, San Diego, CA, USA. Cat. 329903) and anti-human PD-L1-PE (BioLegend, San
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Diego, CA, USA. Cat. 329705). After this, cells were washed with 2 mL of FACS solution (PBS
1X, BSA 1%, Sodium azide 0.01%) and the events were acquired in FACS CyAn™ ADP
(Beckman Coulter, Inc). FACS data were analyzed using FlowJo X 10.0.7r2 software (Tree Star
Inc.)
2.5. Statistics
Statistics were performed with Two-way ANOVA using Bonferroni t-test for all multiple
pairwise comparisons using GraphPad Prism 5 project (©2013 GraphPad Software).
3. Results
3.1. Neutrophils purity
Blood neutrophils from healthy donors were enriched to about 90% purity, which was checked
through staining with Hematoxylin and Eosin (H&E) as well as by flow cytometry parameters
such as cell size (FSC) vs. granularity/internal complexity (SSC) (Figure 1 A, B). PMNs were
incubated either with culture medium alone, LPS, PMA or the various mycobacteria at two
different multiplicity of infection (MOI: 0.1, 1) of Mycobacterium bovis BCG, Mycobacterium
canetti and Mycobacterium tuberculosis H37Rv. To corroborate that isolated neutrophils were
not contaminated with other leukocyte subpopulations, by means of Fluorescence Activated
Cell Sorter (FACS) we evaluated the presence of T lymphocytes (Lc), B Lc and macrophages
(Mfs) using specific antibodies to CD3, CD19 and CD14 (Figure 1 B right panel).
Figure 1. Analysis of peripheral blood neutrophils isolated from healthy donors. Enriched Neutrophils were analyzed
both by staining with H&E (A) and by flow cytometry (B). By flow cytometry (B) we evaluated the Size and Granulari‐
ty (left panel) of the isolated PMNs. The purity of the PMN-enriched cell suspensions was also verified by using mark‐
ers both for T and B cells (right top panel) and macrophages (right bottom panel).
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3.2. Mycobacterium affects neutrophils integrity at early times of interactions
By means of flow cytometry we analyzed the neutrophils incubated either with culture
medium alone, LPS, PMA, Mycobacterium bovis BCG, Mycobacterium canetti or Mycobacterium
tuberculosis H37Rv. We observed an increase in neutrophils autofluorescence, i.e., those that
were incubated only with mycobacteria but that were not labeled with any fluorescent reagent
at all. Autofluorescence was analyzed in a free channel or filter without staining (FL-6=405 nm)
(figure 2). In flow cytometry it has long been described that autofluorescence indicates
(membrane) cell damage or even cell death [22-27]. In this case, the neutrophils incubated with
BCG or with Mtb H37Rv increased their autofluorescence emission since early times of
exposure to mycobacteria. At 15 min of incubation (figure 2B, D) approximately 60-80% of
PMNs were autofluorescent, while for neutrophils interacting with Mycobacterium canetti the
autofluorescence increased approx. 15% at 30 minutes (figure 2G). In contrast, neutrophils
incubated with culture medium alone showed basal levels, approximately 10% of autofluor‐
escence (figure 2 A, E, I)
Figure 2. Mycobacteria of different virulence can induce damage to neutrophils at early exposure times, as determined
by autofluorescence using flow cytometry. Healthy volunteers' neutrophils were incubated 15, 30 and 60 min with ei‐
ther culture medium alone (Medium), Mycobacterium bovis (BCG), Mycobacterium canetti or Mycobacterium tuberculosis
H37Rv. Histograms show the autofluorescence emitted by neutrophils in a free channel (FL-6=405 nm) when using ba‐
cilli at a multiplicity of infection (MOI) of 3:1 for each mycobacterial strain.
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3.3. Mycobacteria do not activate neutrophils at early times of interaction
Blood neutrophils incubated separately with three different strains of Mycobacteria (BCG,
Canetti and Mtb) were evaluated for the expression of CD16b (Figure 3), CD11b and CD66b
(Figure 4), at 15, 30 and 60 min incubation. Although these molecules are constitutively
expressed on neutrophils, it is well documented that neutrophils modify the expression of
these markers upon activation [13, 15, 17, 19, 28-30].
Neutrophils incubated with mycobacteria did not display changes in the percentages of
expression of CD16b (Figure 3A), CD11b, CD66b (Figure 4A, C) at the 3 time-points evaluated.
There was, however, a decreased in the median fluorescence intensity (MFI) for CD16b (figure
3B) and CD66b (figure 4D) and an increment for CD11b (Figure 4B) with Mtb at 15 min
incubation, compared with neutrophils in culture medium alone. Short incubation periods
with the microbial product LPS or with PMA (both used as positive controls) increased the
expression of CD11b (figure 4B) and CD66b (figure 4C), i.e., since 15 min of exposure.
Figure 3. FcγRIIIb-expression in neutrophils exposed to different Mycobacteria. Healthy donor neutrophils were incu‐
bated with medium alone (white bars), LPS (gray bars), PMA (black bars), Mycobacterium bovis (BCG) MOI 0.1 (aqua
bars) and 1 (green bars), Mycobacterium canetti MOI 0.1 (pink bars) and 1 (orange bars) and Mycobacterium tuberculosis
H37Rv MOI 0.1 (blue violet bars) and 1 (red bars). Percentage (A) and MFI (B) of neutrophils labeled for CD16b evalu‐
ated at 15, 30 and 60 min incubation with mycobacteria of different virulence. Error bars denote the s.e.m. and dotted
lines represent the basal level of CD16b expression (A, B). s.e.m: standard error mean, MFI: Median fluorescence inten‐
sity, MOI: Multiplicity of infection, M: Mycobacterium.
3.4. Mycobacteria rapidly induce pro-inhibitory molecules on neutrophils
Mycobacteria have evolved diverse mechanisms to escape, divert or even subvert the immune
responses [4, 31]. The molecular pair PD1-PD-L1 has been recently shown to induce a phe‐
nomenon called T cell exhaustion, and the expression of these two molecules has been shown
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manipulated by certain pathogens for their advantage [32, 33]. The percentage of PD1 expres‐
sion in neutrophils incubated with mycobacteria increased only with Mtb H37Rv (figure 5A,
black arrows) since 15 min, compared with basal expression levels. In contrast, PMNs inter‐
acting with the other mycobacterial strains did not modify the percentage of PD-1 expression
(Figure 5A). Regarding MFI we observed a decrease in PD-1 intensity in neutrophils incubated
with Mtb H37Rv MOI:1 at 15 and 30 min, but an increase at 60 min (figure 5B, black arrow).
With respect to PD-1 Ligand (PD-L1), the percentage increased in neutrophils incubated with
BCG and Mycobacterium canetti at 15 min, compared with basal controls (Figure 5C). Neutro‐
phils incubated with Mtb H37Rv show a tendency to increase the MFI of PD-L1 at 15 and 60
min of incubation (figure 5D, blue arrow), this increase was more clear after 60 min, compared
with basal intensity and with the other mycobacterial strains tested.
Figure 4. Activation kinetics of human neutrophils exposed to different Mycobacteria. Healthy donor neutrophils were
incubated with culture medium alone (white bars), LPS (gray bars), PMA (black bars), Mycobacterium bovis (BCG) MOI
0.1 (aqua bars) and 1 (green bars), Mycobacterium canetti MOI 0.1 (pink bars) and 1 (orange bars) and Mycobacterium
tuberculosis H37Rv MOI 0.1 (blue violet bars) and 1 (red bars). Percentage (A, C) and MFI (B, D) of neutrophils labeled
for CD11b and CD66b evaluated at 15, 30 and 60 min incubation with different bacilli. Error bars denote the s.e.m. and
dotted lines represent CD11b (A,B) and CD66b (C,D) basal expression. *P=0.01; ***P < 0.0001, one-way ANOVA, s.e.m:
standard error mean, MFI: Median fluorescence intensity, MOI: Multiplicity of infection, M: Mycobacterium.
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Figure 5. Kinetics of expression of pro-inhibitory molecules in neutrophils exposed to Mycobacteria at early time
points. Healthy donor neutrophils were incubated with medium alone (white bars), LPS (gray bars), PMA (black bars),
Mycobacterium bovis (BCG) MOI 0.1 (aqua bars) and 1 (green bars), Mycobacterium canetti MOI 0.1 (pink bars) and 1 (or‐
ange bars) and Mycobacterium tuberculosis (Mtb) H37Rv MOI 0.1 (blue violet bars) and 1 (red bars). Percentage (A, C)
and MFI (B, D) of neutrophils labeled for PD-1 and PD-L1 evaluated at 15, 30 and 60 min incubation with different
mycobacteria. Error bars denote the s.e.m. and dotted lines represent the basal levels for PD-1 (A, B) and PD-L1 (C, D).
*P=0.01; **P=0.001; ***P < 0.0001, one-way ANOVA, s.e.m: standard error mean, MFI: Median fluorescence intensity,
MOI: Multiplicity of infection, M: Mycobacterium.
4. Discussion
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB) [1]. According to the
World Health Organization (WHO), TB caused the death of 1.3 million people worldwide in
2012 [2]. Despite the vast amount of TB research in more than 100 years, there are still many
aspects of the disease that remain poorly known, for instance the host’s innate response during
the earliest stages of the infection. The involvement of neutrophils in the immune response
against Mtb has been rather neglected until recently. Conceivably, this might be due to the
short life span of these cells, the quickness of their mechanisms of action and also to the
chronicity of TB.
We aimed at assessing activation as well as pro-inhibitory molecules on neutrophils from
healthy donors using flow cytometry, thus PMNs were incubated for short periods with three
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different strains of mycobacteria. As positive controls for PMN activation at the time points
evaluated, we used two standard components, a microbial one such as lipopolysaccharide
(LPS), and a chemical one such as phorbol myristate acetate (PMA). At least two main FACS
criteria were evaluated, the percentage of cells and the median fluorescence intensity (MFI).
The latter directly reflects the intensity of expression of a given molecule in the cells evaluated.
In flow cytometry the emission of autofluorescence in both animal and plants cells has been
indicative of cell damage or even cell death. In addition, the reduction of NADH induces
intracellular fluorescence, also indicating cell damage [22-27]. When we cultured mycobacteria
with neutrophils, these increased their autofluorescence emission since 15 min, compared with
neutrophils in medium alone. Previously, Perskvist et al. (2002) demonstrated that Mtb H37Rv
induced apoptosis in neutrophils, but this was evaluated at 5h of interaction [34, 35]. However
other studies of neutrophils with Leishmania major showed increased IL-8 production and
inhibition of apoptosis at 24h [36]. Corleis et al. (2012) described that at 20 min, neutrophils can
kill Mycobacterium smegmatis but not Mycobacterium tuberculosis [37]. In addition, Ramos-Kichik
et al. (2009) showed that Mtb induced neutrophil extracellular traps (NETs) at 180 min [38],
compared with other microorganisms such as C. albicans that do it in shorter time [39].
Few and recent studies have focused on the effects that mycobacteria might have on neutro‐
phils [40-42], for instance whether mycobacteria can induce neutrophil extracellular traps, as
seen when PMNs interact with other microorganisms [38]. Of note, even the phenotype of
neutrophils during and after their interaction with mycobacteria remains poorly addressed.
From the set of molecules that we measured, some (CD16b, CD11b, CD66b) are well established
neutrophil activation markers, while the others (PD1/PD1-L) are very important pro-inhibitory
molecules. Interestingly, however, even at the longest time of incubation with mycobacteria
(60 min), we did not observe statistically significant differences in the percentages of PMNs
expressing CD16b, CD11b or CD66b, compared to neutrophils incubated with the control
substances LPS, PMA or with culture medium alone. In contrast, it is known that certain
components from microorganisms such as E. coli, S. thyphimurium. S. flexneri and Y. enteroco‐
litica induce activation of neutrophils at early times (30 min) of exposure [43]. Interestingly,
even at 15 min incubation the percentage and the MFI of CD11b, CD66b, CD18 or CD62L
increased in human healthy neutrophils incubated with DNA of E. coli, LPS, fMLP, C5a and
three different strains of Staphylococcus aureus [19, 44].
On the other hand, decrease in surface CD16b in neutrophils is also related to the activation
of these cells [29, 30]. When we analyzed the median fluorescence intensity (MFI) of CD16b on
mycobacteria-incubated neutrophils, we did not find significant differences compared to the
controls, although there was a slight decrease at 15 minutes in cells incubated with Mtb H37Rv
compared to freshly isolated neutrophils. Regarding the expression of CD11b and CD66b, both
LPS and PMA (used as positive controls for stimulation), increased the expression of these two
markers since 15 minutes compared to neutrophils in medium alone, indicative of the intact
capacity of neutrophils to respond. Although there was a subtle decrease in CD66b expression
at 15 minutes of incubation with bacilli, compared to freshly isolated neutrophils.
Previous studies have evaluated the expression of CD16b and CD66b as activation markers in
neutrophils from patients with active TB [45]. Likewise, in healthy neutrophils incubated with
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clinical isolates of Mtb, the expression of CD16, CD69 and CXCR2 was evaluated, but only at
3 and 18 h [46]. Hilda et al. in 2012 demonstrated that the virulent strain Mtb H37Rv can
modulate the expression of FcγRII (CD32), FcγRI (CD64), TLR-4 and CXCR3 in neutrophils,
while BCG increased CD32 expression only, and a vaccine strain, Mycobacterium indicus
pranii, did not produce any apparent effect with MOI: 3, all at 4h of incubation [47]. We did
not see differences in neutrophil activation in response to the three strains of mycobacteria,
regardless of their different virulence.
The PD-1/PD-L1 pathway is important for the establishment and maintenance of peripheral
tolerance as well as to modulate immune and inflammatory responses to pathogens [21, 48].
This pathway has been found altered during chronic viral [49, 50], parasitic [51], fungal [52]
and bacterial [32] infections, provoking a phenomenon known as “exhaustion” in CD8+T cells,
exerting an inhibitory effect related to pathogens evasion of immune responses [20]. Appa‐
rently, Mtb H37Rv can also modulate and manipulate the PD/PD-L1 path not only in T cells,
but also in antigen presenting cells and even in elements of the innate immune response, such
as NK cells [53]. However, this pair of molecules has been poorly explored in neutrophils,
especially in the interplay with microorganisms. Therefore, we sought to evaluate also the
neutrophils expression of PD-1 and PD-L1 in the early response to mycobacteria. There was
an apparent increase in the proportion of neutrophils expressing surface PD-1 following
incubation with Mtb H37Rv (MOI 1), which was more evident at 60 minutes; although not
statistically significant. These results are interesting and opposed to data by Yao et al. (2009)
where they reported that neither NK cells, macrophages nor neutrophils express PD-1 during
infection with Listeria monocytogenes [54]. On the other hand, we did not observe changes in
the proportion of neutrophils expressing PD-L1 after incubation with the different mycobac‐
teria strains at the time points we evaluated. Regarding the mean fluorescence intensity (MFI)
of PD-1, we observed that at 15 and 30 min there were no differences in its expression in
neutrophils incubated with mycobacteria. However, at 60 min the expression of PD-1 increased
importantly in neutrophils but only with Mtb H37Rv at MOI 1. When evaluating the MFI for
PD-L1 we did not find significant differences among neutrophils incubated with mycobacteria
or with culture medium alone. McNab et al. (2011) also evaluated these pro-inhibitory
molecules but at the mRNA level in the blood from tuberculosis patients [55]. They found that
the polymorphonuclear population overexpressed the PD-1 ligand in patients with active TB,
in comparison to patients with latent TB and healthy donors.
Our results indicate that, while neutrophils are readily stimulated upon short time of incuba‐
tion with either LPS or PMA, they do not get activated during early interactions with three
mycobacteria of different virulence. This is revealed by the PMNs inability to modify activation
molecules which are involved in crucial processes such as migration, adhesion, phagocytosis
and degranulation. However, at these early times of interactions with mycobacteria, there are
indeed alterations occurring in other important molecules in PMNs, such as PD1/PD1-L.
It is conceivable that early during a mycobacterial infection neutrophils might encounter and
interact with other recruited cells of the immune system while still expressing inhibitory
molecules such as PD-1 or PD-L1, thus limiting the intensity of the response at the site of
infection. The fact that neutrophils infected with Mtb express both the receptor and the ligand
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of PD-1 could be related to an autocrine regulation of this population. Further experiments are
required to understand the role of the early innate immune response against Mycobacterium
tuberculosis. Since there are few studies focused on the neutrophils phenotype during the very
early interactions with mycobacteria, we consider our results of interest and we expect that
this work will instigate more research on the participation of neutrophils during the early
stages of mycobacterial infection.
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